MDCXW MEDICUS PHARMA LTD
Follow*W EXP 11/15/202 (warrant or right), issuer CIK 1997296
Filings received so far for Q3 2026: 7 13F filers report a position in MDCXW shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Private Advisor Group, LLC | 43,500 | $13.1K | <0.01% | new | 13F-HRTimeline |
| Anson Funds Management LPin group Anson Funds Management LP | 42,400 | $12.7K | <0.01% | 0 | 13F-HRTimelineGroup |
| Corient Private Wealth LPin group Corient Private Wealth LP | 15,000 | $4.5K | <0.01% | new | 13F-HRTimelineGroup |
| Connective Capital Management, LLC | 6,000 | $1.8K | <0.01% | 0 | 13F-HRTimeline |
| UBS Group AGin group UBS Group AG | 1,780 | $534 | <0.01% | -423 | 13F-HRTimelineGroup |
| ARMISTICE CAPITAL, LLCin group ARMISTICE CAPITAL, LLC | 60,600 | $364 | <0.01% | 0 | 13F-HRTimelineGroup |
| Clear Street Group Inc.in group Clear Street Group Inc. | 89 | $27 | <0.01% | new | 13F-HRTimelineGroup |